The Towering Lies of President Trump It’s simple.

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
220
The Towering Lies of President Trump

It’s simple. Everything that benefits Mr. Trump is true and everything that inconveniences him is false.


By Greg Weiner



That is a more plausible explanation for his early denials than the president’s claim that he downplayed the coronavirus to prevent panic. Honesty about dangers, and a clear strategy for overcoming them, prevent panic. Lies fuel it, unless the panic to which Mr. Trump referred was personal fear about his own interests.

Credit...Tyler Comrie

https://www.nytimes.com/2020/09/11/opinion/su...e9f650852d

President Trump’s taped admission to Bob Woodward that he deliberately misled Americans about the danger of the coronavirus makes him morally culpable in the ensuing tragedy. But Mr. Trump actually forfeited the battle against the pandemic long before it erupted in Wuhan, China, in the first place. His tragic failures are a result of a systematic skepticism — an opportunistic cynicism — whose orienting principle is that everything that benefits Mr. Trump is true and everything that inconveniences him is false.

Five centuries ago, Niccolò Machiavelli called this the “effectual truth”: Claims that are true, he wrote in “The Prince,” are so not because they correspond to objective reality but because they are politically “useful.”

Mr. Trump’s use of skepticism as a standard for interpreting reality now risks undermining public faith in an eventual vaccine.

In his capstone address to the Republican National Convention, Mr. Trump promised a vaccine “before the end of the year or maybe even sooner.” That might be written off as a mere prediction of events, except that Mr. Trump tipped his hand in a pair of tweets directed against the Food and Drug Administration.

Together, they displayed the systematic skepticism that has derailed the administration’s pandemic response. But that skepticism is not isolated to the pandemic. Its degrading effects on politics may, instead, be one of Mr. Trump’s most regrettable and enduring legacies.

In one tweet, Mr. Trump rebuked the F.D.A. for revoking its emergency authorization of hydroxychloroquine, the antimalarial drug the president has repeatedly touted as a coronavirus treatment: “Many doctors and studies disagree with this!”

This is almost certainly accurate in the strict sense that “many” refers to an unspecified number exceeding one. Especially in the early and uncertain period of a new disease, scientific opinions are like parenting books and diet fads: One can go looking for something that confirms a prior conviction and be certain to find it.

That is different from trying to make the best judgment one can on the basis of competing views, some of which are more credible and authoritative than others. The fact that “many” people are willing to say anything, especially if the president cues them to do so, proves nothing except adherence to an intellectually and morally corrosive belief that nothing can be proved.

Early in this administration, it was reasonable to say that plausibility was the new truth: The mere existence of a believable opposing claim was sufficient to rebut a balanced assessment of the totality of the evidence. But when skepticism is a whole system of thought, assertion is the new truth. A claim no longer needs to be believable. It simply needs to be made.

Mr. Trump started down that road before he was inaugurated, preposterously claiming that millions of fraudulent ballots cheated him out of the 2016 popular vote. Machiavelli would recognize the terms in which Mr. Trump recently recast this claim: that he won in “a true sense.”

Mr. Trump continued within hours of taking the presidential oath, forcing his staff to insist against photographic evidence that the crowd at his inauguration had been the largest in history.

That skepticism now appears to be guiding the search for a vaccine. The same morning Mr. Trump insisted on the effectiveness of hydroxychloroquine, another presidential tweet accused “the deep state, or whoever, over at the FDA” of “making it very difficult for drug companies to get people in order to test the vaccines and therapeutics. Obviously, they are hoping to delay the answer until after November 3rd.”

He proceeded to demand a “a focus on speed, and saving lives.” But the reference to Election Day was the giveaway: The question for Mr. Trump was not simply whether the F.D.A. was dragging its feet or elevating medical caution over the urgency of a vaccine. That is a legitimate debate that must weigh the unknown long-term effects of an insufficiently tested vaccine with the known and immediate effects of its unavailability.

By contrast, Mr. Trump was concerned not with prudential or objective assessments of proposed vaccines but rather with their “effectual truth.” By definition, the F.D.A. was moving too slowly because moving more quickly would help him politically.

A degree of skepticism can be a healthy disposition. Politically, it encourages the wariness of concentrated power appropriate to a republic. Intellectually, it values a prudent humility about what we can know over the certitude to which expertise is often prone.

But skepticism as a system for interpreting the world — which conservatives might once have called “nihilism” — is different from skepticism as a disposition. Systematic skepticism axiomatically questions the truth or relevance of anything that does not serve Mr. Trump’s personal ambition.

What has happened since the pandemic arrived in the United States has simply been the application of that system of thought to unfolding events. What is good for Mr. Trump is good for the nation, and a pandemic is not good for Mr. Trump.

That is a more plausible explanation for his early denials than the president’s claim that he downplayed the coronavirus to prevent panic. Honesty about dangers, and a clear strategy for overcoming them, prevent panic. Lies fuel it, unless the panic to which Mr. Trump referred was personal fear about his own interests.

As a result of all this, the still evolving science surrounding Covid-19 is routinely interpreted based on its perceived effects on Mr. Trump’s re-election. The president’s personal refusal to wear a mask except when it seems politically convenient to do so — and his outright mocking of those who have worn them — has transformed the single most effective device for preventing contagion into a statement of political loyalties. That has vastly more to do with the pandemic’s tragic toll than Mr. Trump’s policy choices do.

A Republican sheriff in Florida recently went as far as banning masks for deputies on duty and even for visitors to his office. The sheriff’s reasoning about wearing masks, which made national news, was rooted in systematic skepticism. He claimed that the effectiveness of masks was disproved by the fact that someone, somewhere, disputed it: “The fact is, the amount of professionals that give the reasons we should, I can find the exact same amount of professionals that say why we shouldn’t.” On the other side of the landscape are Trump supporters who claim that his lies are obvious and transparent whoppers that no one believes, which is evidently untrue.

At this point, there is every reason to worry that a vaccine will be approved on an emergency basis before its safety has been fully established. The absurdity of the situation distills to this: Pharmaceutical executives, who have pledged not to seek authorization for a vaccine until adequate scientific evidence is gathered, are now acting as a check on federal regulators rather than the other way around.

Absent systematic skepticism, the balance of considerations might justify rapid authorization. But Mr. Trump has undermined any reason for confidence in such a judgment by staking his claim to the effectual rather than the actual truth.

When a vaccine is actually ready, public trust in it will be a vital tool for ending the pandemic. On the other hand, should a vaccine suddenly appear on the eve of the election under obvious political pressure, the systematic skeptics who interpret truth through Mr. Trump’s eyes could prove their fidelity to him by being the first in line to receive it.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 172

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading
Yunji Rolls Out AI Robots at EquipHotel Paris 2026

Updated Category News Views 95

AI Takes Center Stage in Hospitality When someone mentions a new revolution in hospitality, I usually roll my eyes. But this time, Yunji Technology (HKEX: 02670) is bringing something to the table that's hard to ignore. They’re out in full force at EquipHotel Paris 2026, flaunting their AI-powered collection of service bots with the kind of confidence that says, 'We're...

Continue Reading
Syra Health Hits Record Revenue, Sustains Growth

Updated Category News Views 89

Syra Health Reports Stellar Q3 Performance Folks, let's dive right into the figures: Syra Health's Q3 2026 performance is nothing short of a powerhouse display. We're talking about a jaw-dropping 52% surge in revenue compared to the same period last year, climbing to a record $2.6 million. It's not often you see a company swing its EPS from a loss of $(0.02) to a positive...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 68

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Chunghwa's Q3 2026 Results Show Revenue and Profit Boom

Updated Category News Views 14

Revenue Rises Beyond Expectations Well, if there's ever a time to keep your telecom stocks in your sight, it's right now with Chunghwa Telecom. They just rolled out their unaudited Q3 2026 results, and it's like a firework show of numbers—lighting up the sky with a whopping revenue increase by 16.7% to NT$ 67.59 billion. Whatever they're feeding their cash registers...

Continue Reading
LUX Infusion Expands in Nebraska with New Acquisitions

Updated Category News Views 130

Strategic Expansion: LUX Infusion's Bold Move When it comes to healthcare, it's often about pulling the right strings at the right time, and today, LUX Infusion's got their timing spot on. They've swooped in with a savvy acquisition, taking over two key specialty infusion centers in Lincoln and Omaha. This isn't just a pencil-pusher's cynical corporate move; it's a push...

Continue Reading
Meiyume Unveils Futuristic Beauty Experience at Event

Updated Category News Views 55

Turning Heads in the World of Beauty Let's dive into the vibrant world of beauty innovation, where Meiyume's latest showcase at Cosmopack Asia 2026 has been the talk of the town. Located at Booth 3-C01, Meiyume introduced BEACON, a revolutionary experience that aims to guide brands in spotting market opportunities and realizing them through a connected global ecosystem....

Continue Reading
Staypineapple Backs Vets: A Heartwarming Initiative

Updated Category News Views 129

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Continue Reading
Orlando's Holiday Extravaganza: Theme Parks to Unique Festivities

Updated Category News Views 67

Holiday Cheer Abounds in Orlando Orlando's never a letdown when it comes to spectacle, but this holiday season, they've taken it up a notch and a half. The city's bursting with festivities, from the iconic theme parks to lively local events that offer something for everyone. Whether you're entertaining kids or looking for grown-up glitz, Orlando's got you sorted. Merry...

Continue Reading
Edible Oils: Market Growth, Trends, and Investments

Updated Category News Views 167

Riding the Edible Oil Wave The edible oils market seems to be gearing up for a steady rise. Folks, the numbers are speaking loud and clear. We're looking at the market booming from USD 277.74 billion in 2026 to a hefty USD 351.08 billion in 2031. According to MarketsandMarkets™, a compound annual growth rate (CAGR) of 4.8% is on the cards. Now, if that doesn't get the...

Continue Reading

Top 5 Most Recently Viewed Articles

Assystem Reports Key Liquidity Contract Details for Investors

Updated Category News Views 141

Half-Year Liquidity Contract Statement from Assystem Assystem S.A., a prominent player in the nuclear engineering sector, recently disclosed important information regarding its liquidity contract as of June 30, 2025. The company, which focuses on optimizing performance in highly regulated industries, has numerous commitments aimed at forging a low-carbon future. This...

Continue Reading
Clear Channel Outdoor to Divest Spain Business to Atresmedia

Updated Category News Views 215

Clear Channel Outdoor Sells Spanish Operations to Atresmedia Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) has made a significant decision to divest its operations in Spain by entering into a definitive agreement with Atresmedia Corporación de Medios de Comunicación, S.A. This move indicates the company's intent to focus its resources and attention on its core...

Continue Reading
Air Taxi Stocks Soar Following Vertical Aerospace Funding Update

Updated Category News Views 254

Air Taxi Industry Reacts to Major Investment Recently, the air taxi industry experienced a remarkable surge in stock values, spurred by an exciting investment in Vertical Aerospace. This company focuses on electric vertical take-off and landing (eVTOL) aircraft and made headlines after securing new funding that saw its stock price soar by 40%. Within this context,...

Continue Reading
Citius Oncology and Er-Kim Collaborate for LYMPHIR Expansion

Updated Category News Views 197

Citius Oncology and Er-Kim Collaborate for LYMPHIR Expansion In an exciting partnership, Citius Oncology, Inc. (Nasdaq: CTOR) has entered into an exclusive agreement with Er-Kim ?laç Sanayi ve Ticaret A.?. to distribute LYMPHIR (denileukin diftitox-cxdl) across Turkey and several Middle Eastern countries. This collaboration aims to enhance the availability of this...

Continue Reading
Nio's Recent Surge: Boosting Deliveries and Cash Flow

Updated Category News Views 207

Nio's resounding success back in 2024 sent shockwaves through the electric vehicle (EV) sector, with shares surging an impressive 65% as traders caught wind of the delivery numbers. The sentiment from investors was clear: 'Let the good times roll'. Nio wasn't just riding a short-lived wave; they had solid fundamentals undergirding their gains. A combination of new model...

Continue Reading